相关实验视频
Updated: May 10, 2025

08:09
Isolation, Culture, and Imaging of Human Fetal Pancreatic Cell Clusters
Published on: May 18, 2014
14.1K
循环GDF-15与胎儿生长在妊娠糖尿病中的关联
Tiziana Filardi1,2, Enrico Bleve2, Valentina Viggiani3
1Department for the Promotion of Human Sciences and Quality of Life, San Raffaele Roma Open University, Via di Val Cannuta, 247, 00166 Rome, Italy.
Journal of clinical medicine
|April 26, 2025
概括
增长差异化因子-15 (GDF-15) 可能在妊娠糖尿病 (GDM) 中防止胎儿过度生长. 在GDM患者中,更高的GDF-15水平与不良的周产期结果有关,这表明它可能在妊娠并发症中起作用.
科学领域:
- 生殖生物学和内分泌学.
- 妊娠中的代谢障碍 妊娠中的代谢障碍
- 在产科中使用炎症标志物.
背景情况:
- 增长差异化因子-15 (GDF-15),TGF-β超级家族的一员,涉及到炎症调节.
- 需要研究GDF-15对葡萄糖失调的潜在保护作用,特别是在怀孕期间.
- 孕期糖尿病 (GDM) 对母亲和胎儿的健康都有风险,需要识别预测生物标志物.
研究的目的:
- 研究血清GDF-15度与GDM中的代谢/炎症标志物之间的关联.
- 探索GDF-15水平与患有GDM的妇女不良产周结局之间的关系.
- 评估GDF-15作为GDM相关并发症的潜在生物标志物.
主要方法:
- 一项试点研究涉及24名GDM患者和29名正常葡萄糖耐受 (NGT) 的孕妇在他们的第三个三个月.
- 使用ELISA测量血清GDF-15,小密度低密度脂蛋白胆固醇 (sdLDL),互白素-6 (IL-6) 和可溶性尿素酶等离子体激活受体 (su-PAR).
- 评估胎儿超声波参数,产妇,分娩和围产期的结果.
主要成果:
- 血清GDF-15水平在GDM和NGT组之间没有显著差异.
- 在GDM患者中,GDF-15与胎儿体重百分点呈现负相关性,即使调整了BMI.
- 较高的GDF-15水平与IL-6正相关,并且与不良周产期结果的可能性增加有关.
结论:
- 在GDM中,GDF-15可能对胎儿过度生长起着保护作用,可能减轻高血糖的影响.
- 在GDM怀孕中,高GDF-15水平与不良围产期结局有关.
- GDF-15值得进一步研究,因为它是管理GDM及其并发症的潜在生物标志物.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.1K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.1K
Pathophysiology of Diabetes
807
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
807
Hypoglycemia and Glucagon
138
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
138
Diabetes: Symptoms, Diagnosis, and Complications
475
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
475
Glucagon-like Receptor Agonists
261
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
261
Hormones Regulating Blood Glucose
2.9K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
2.9K

